Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Bharat Biotech seeks full marketing approval from DCGI for Covaxin
The company, however, is yet to submit the full follow up data of clinical trial of Covaxin to DCGI, a source said.
43 per cent pharma marketers prefer programmatic messaging platforms in India: Doceree
Doceree delved into inventory and campaign behaviour trends of its multiple partners, studying over 1,100 campaigns. These were…
Glenmark gets US FDA nod for nasal spray to treat seasonal allergic rhinitis
With this NDA approval, the company looks forward to bringing this new medicine to physicians and their patients for the treatment…
AstraZeneca welcomes US government’s announcement to purchase additional 500,000 doses of…
Evusheld has Emergency Use Authorisation (EUA) for pre-exposure prophylaxis (prevention) of COVID-19
Pfizer’s Prevnar 20 with Pfizer-BioNTech COVID-19 vaccine shows positive results in phase-III study
responses elicited by Prevnar 20 for all 20 serotypes were similar whether given with a dose of the Pfizer-BioNTech COVID-19…
Aragen acquires Intox
Strengthens discovery-to-development integrated platform with the addition of GLP-certified safety-assessment capabilities
Covaxin booster neutralises Omicron and Delta variants of SARS-CoV-2: Study
Hundred per cent of test serum samples showed neutralisation of the Delta variant and more than 90 per cent of serum samples…
Is your lab positioned to achieve your goals?
Meeting your organization’s scientific and business objectives requires productive lab instruments, a clear line of sight into…
S Korea authorises use of Novavax COVID-19 vaccine
South Korean vaccine developer SK Bioscience said it will produce the Novavax vaccine
WHO body says COVID-19 vaccines ‘may need to be updated’ for Omicron
The technical group, made up of independent experts, said it would consider a change in vaccination composition and stressed that…